Exploring Technologies for cGMP Success with Encapsulation of Nucleic Acid-based Therapeutics

In this white paper, Lonza Biologics discuss the challenges and opportunities associated with nucleic acid encapsulation technologies with a particular focus on mRNA encapsulation. Lonza also shares some of their insights into the key requirements for their LNP toolbox and how this approach facilitates a low-risk transition from pre-clinical stages to cGMP production.